SYRE 股东权益历史(2016–2025)
SPYRE THERAPEUTICS, INC. (SYRE) 各财年年末股东权益(来自 SEC 财报)。
$715.2MFY2025 · FY2016 以来:$63.0M → $715.2M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $715.2M | +38.1% |
| FY2024 | $517.8M | +181.4% |
| FY2023 | $184.0M | +265.8% |
| FY2022 | $50.3M | -40.1% |
| FY2021 | $83.9M | -40.0% |
| FY2020 | $139.8M | +132.7% |
| FY2019 | $60.1M | -10.9% |
| FY2018 | $67.4M | +34.0% |
| FY2017 | $50.3M | -20.1% |
| FY2016 | $63.0M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议